Levofloxacin

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

57 API Suppliers, 27 USDMF, 11 JDMF, 7 EU WC, 26 KDMF, 21 NDC API, 25 Listed Suppliers

DEVELOPMENTS

3 Drug(s) in Development

3 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

3 Suppliers

3 Suppliers

DOSSIERs // Finished Dosage Formulations

501 Dossiers, 119 FDA Orange Book, 189 Europe, 19 Canada, 57 South Africa, 117 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 750MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION/DROPS;OPHTHALMIC - 0.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION/DROPS;OPHTHALMIC - 1.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;ORAL - 250MG/10ML

TABLET;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 750MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SOLUTION/DROPS;OPHTHALMIC - 0.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SOLUTION/DROPS;OPHTHALMIC - 1.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SOLUTION;ORAL - 250MG/10ML

RELATED EXCIPIENT COMPANIES

Suppliers, 30 Kerry, 24 BASF, 23 Roquette, 15 Actylis, 14 Seppic, 13 Microlex e.U, 12 Sigachi Industries, 11 Gangwal Chemicals, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 Corel Pharma Chem, 10 Gangwal Healthcare, 8 Boai NKY Pharmaceuticals Ltd, 6 Lonza Capsugel, 6 DFE Pharma, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 6 Nanjing Well Pharmaceutical, 5 Ideal Cures Pvt Ltd, 4 Pharmatrans-Sanaq, 4 Prachin Chemical, 4 Ingredion Pharma Solutions, 4 Finar, 4 Vasa Pharmachem, 4 SPI Pharma, 3 DKSH, 3 Ulanqab Kema New Material, 3 Kima Chemical, 2 The Dow Chemical Company, 2 Rochem International Inc, 2 Seqens, 2 Nomisma Healthcare, 2 Jai Radhe Sales, 1 Aeon Procare, 1 Qualicaps, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Bioplus Life Sciences, 1 Pharm-RX Chemical, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Clariant, 1 Alcedo Pharmachem, 1 Pfanstiehl, 1 Nanjing Bold Chemical, 1 ACG Worldwide

EXCIPIENTS BY APPLICATIONS

66 Fillers, Diluents & Binders, 46 Coating Systems & Additives, 42 Disintegrants & Superdisintegrants, 34 Direct Compression, 30 Solubilizers, 28 Controlled & Modified Release, 25 Thickeners and Stabilizers, 24 Granulation, 22 Parenteral, 17 Topical, 16 Lubricants & Glidants, 13 Film Formers & Plasticizers, 13 Co-Processed Excipients, 13 Taste Masking, 9 Chewable & Orodispersible Aids, 6 API Stability Enhancers, 6 Emulsifying Agents, 5 Empty Capsules, 5 Rheology Modifiers, 4 Vegetarian Capsules, 3 Surfactant & Foaming Agents, 2 Coloring Agents